Back to Authors

Cronin, Richard

Mayo Clinic

RPC Consultants Waterfall Nr Cork Ireland

Citations 2

Abnormal Variable Contrast Acuity in Parkinson's Disease (P04.143)
Lin, Tanya, Adler, Charles, Hentz, Joseph G. , Adler, Jennifer S. , Balcer, Laura J. , Galetta, Steven , Devick, Steve , Cronin, Richard

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p04.143 Get It

Abnormal Visual Contrast Acuity in Parkinson's Disease
Lin, Tanya, Rigby, Heather, Adler, Jennifer S. , Hentz, Joseph G. , Balcer, Laura J. , Galetta, Steven , Devick, Steve , Cronin, Richard, Adler, Charles H.

Journal of Parkinson’s Disease | December 3, 2019 | Volume: 5 | Issue: 1 | Pages: 125-130

10.3233/jpd-140470 Get It

Background: Low-contrast vision is thought to be reduced in Parkinson's disease (PD). This may have a direct impact on quality of life such as driving, using tools, finding objects, and mobility in low-light condition. Low-contrast letter acuity testing has been successful in assessing low-contrast vision in multiple sclerosis. We report the use of a new iPad application to measure low-contrast acuity in patients with PD. Objective: To evaluate low- and high-contrast letter acuity in PD patients and controls using a variable contrast acuity eye chart developed for the Apple iPad. Methods: Thirty-two PD and 71 control subjects were studied. Subjects viewed the Variable Contrast Acuity Chart on an iPad with both eyes open at two distances (40 cm and 2 m) and at high contrast (black and white visual acuity) and 2.5% low contrast. Acuity scores for the two groups were compared. Results: PD patients had significantly lower scores (indicating worse vision) for 2.5% low contrast at both distances and for high contrast at 2 m (p < 0.003) compared to controls. No significant difference was found between the two groups for high contrast at 40 cm (p = 0.12). Conclusions: Parkinson's disease patients have reduced low and high contrast acuity compared to controls. An iPad app, as used in this study, could serve as a quick screening tool to complement more formal testing of patients with PD and other neurologic disorders.